A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.
Conditions: SARS CoV 2 Infection Interventions: Biological: Johnson& Johnson Sponsors: Jens D Lundgren, MD; Ministry of the Interior and Health, Denmark Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)
Conditions: SARS-CoV-2 Acute Respiratory Disease Interventions: Diagnostic Test: NeuMoDx SARS-CoV-2 Assay Sponsors: QIAGEN Gaithersburg, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults
Conditions: SARS-CoV-2 Interventions: Biological: Investigational mRNA-1273.815; Biological: Licensed Spikevax Vaccine Sponsors: ModernaTX, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
Conditions: Hematologic Diseases Interventions: Diagnostic Test: Complete Blood Count; Diagnostic Test: C-reactive protein; Diagnostic Test: O2 saturation; Diagnostic Test: Serum ferritin and D-dimer; Diagnostic Test: Liver and renal function tests; Diagnostic Test: Lactate dehydrogenase; Diagnostic Test: coronavirus (SARS-CoV-2) swab; Radiation: CT chest Sponsors: New Valley University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients
Conditions: Apnea, Obstructive Sleep; SARS CoV 2 Infection Interventions: Biological: Influvac Tetra Sponsors: Parc Taul í Hospital Universitari Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
Conditions: COVID-19 Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
Conditions: SARS-CoV-2 Interventions: Biological: SPIKEVAX Bivalent; Biological: SPIKEVAX X Sponsors: ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Burn Injuries During COVID-19 Pandemic and Its Influence on Length of Stay
Conditions: SARS-CoV-2 Infection Interventions: Procedure: Burn Injuries Graft Surgery Sponsors: Hamad Medical Corporation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
Conditions: Advanced Respiratory Disease; Chronic Breathlessness Due to Advanced Respiratory Disease; Chronic Obstructive Pulmonary Disease; Bronchiectasis; Interstitial Lung Disease; Lung Cancer; Asthma; Chronic Fibrotic Lung Disease Following SARS-CoV2 Infection Interventions: Other: SELF-BREATHE Sponsors: King ' s College Hospital NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection
Conditions: Breast Cancer; COVID-19; Postoperative Complications Interventions: Other: Preoperative resolved COVID-19 Sponsors: Fujian Medical University Union Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19
Conditions: SARS-CoV-2 Infection Interventions: Diagnostic Test: lung function testing Sponsors: University of Rostock Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Conditions: PASC Post Acute Sequelae of COVID 19; Long COVID Interventions: Drug: 1500 Valacyclovir 200 Celecoxib; Drug: 750 Valacyclovir 200 Celecoxib; Drug: Placebo Sponsors: Bateman Horne Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.
Conditions: COVID-19 Interventions: Other: Analisys of cellular response and humoral response to SARS-CoV-2 vaccine booster doses Sponsors: IRCCS Sacro Cuore Don Calabria di Negrar Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
DiscussionAlthough ME/CFS including PACS-CFS causes an immense individual, social, and economic burden, we lack efficient therapeutic options. The present study aims to investigate the efficacy of immunoadsorption and to contribute to the etiological understanding and establishment of diagnostic tools for ME/CFS.Trial registrationRegistration Number:NCT05710770. Registered on 02 February 2023. (Source: Trials)
Source: Trials - March 7, 2024 Category: Research Source Type: clinical trials
Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.
Conditions: Coronavirus Disease 2019; Severe Acute Respiratory Syndrome Coronavirus 2 Infection Interventions: Combination Product: Kang Guan Recipe (Treat); Combination Product: Kang Guan Recipe (Placebo) Sponsors: Sheng-Teng Huang Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
